LabCorp Central Laboratory Services supplier risk profile Q1 2026: Mexico-focused pharmaceutical importer, 133 shipments, 4 suppliers, B-grade compliance.
LabCorp Central Laboratory Services imported 133 shipments in Q1 2026 across four suppliers, all based in Mexico (100% of volume). Pharmaceutical preparations dominated the import mix, with HS Chapter 30 products representing the largest share alongside organic chemicals and miscellaneous items. Pfizer led supplier volume with 53 shipments, followed by Merck Sharp Dohme Comercializadora with 34 shipments.
Trigram screen against OFAC SDN, BIS Entity List, UFLPA Entity List, SAM Exclusions, EU FSF, UK HMT, UN SC, and 25+ allied jurisdictions.
Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.
The importer registered zero sanctions watchlist matches and zero suppliers with confirmed UFLPA forced-labor exposure in available supply-chain records. No compliance flags were identified during Q1 2026 monitoring.
4 distinct tier-1 suppliers in Q1 2026
| PFIZER | Mexico | 53 |
| MERCK SHARP DOHME COMERCIALIZADORA | Mexico | 34 |
| RPS RESEARCH SERVICIOS | Mexico | 29 |
| ELI LILLY Y COMPABIA DE MEXICO | Mexico | 17 |
Share of Q1 2026 inbound shipments by source country
4 tier-2 + 117 tier-3 nodes mapped - sign up to see them.
Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.